查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1603858

2030 年組織庫市場預測：按產品類型、組織庫類型、儲存技術、應用、最終用戶和地區進行的全球分析

Tissue Banking Market Forecasts to 2030 - Global Analysis By Product Type, Tissue Bank Type, Storage Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球組織庫市場規模將達到 36 億美元，預計到 2030 年將達到 57 億美元，預測期內複合年成長率為 7.8%。

組織庫收集、處理、儲存和分發人體組織用於醫學研究、教育和移植。組織庫從已故捐贈者和接受手術的活體捐贈者那裡獲取組織。收集的組織經過嚴格的測試和處理，以確保其安全性和適用性。然後將其在受控條件下儲存（通常是冷凍的），直到需要用於移植或研究目的。組織庫透過為研究、教育和移植提供必要的資源，在推動醫學發展和改善患者照護方面發揮關鍵作用。

根據世界衛生組織最近發布的資料，慢性病是世界上最大的問題之一，約佔全球整體死亡人數的60%。

慢性病增加

糖尿病、心血管疾病和癌症等慢性疾病的盛行率不斷上升，推動了對組織庫服務的需求。由於這些疾病通常需要高級研究、個人化治療和器官移植，因此組織庫在提供必要的生物樣本方面發揮關鍵作用。研究、診斷和治療目的對專用組織的需求不斷成長，支持了醫療保健和精準醫學的進步，並推動了市場擴張。

道德問題和監管障礙

道德問題和監管障礙給市場帶來了重大挑戰。圍繞知情同意、捐贈者隱私和生物樣本潛在濫用的問題造成了道德困境。此外，有關組織收集、儲存和分發的嚴格規定會減慢組織庫的研究速度並增加營運成本。這些障礙可能會限制科學進步的樣本可用性，並阻礙醫學研究、再生醫學和個人化治療的進步。

老年人口增加

老年人口的增加對市場產生了重大影響。由於老年人更容易患慢性病並需要器官移植和專門治療，因此對保存的生物樣本的需求不斷增加。組織庫對於為研究、再生醫學和移植提供組織至關重要，並有助於解決與老齡化相關的健康問題。這些人口結構的變化有助於擴大組織庫市場，推動技術創新，並改善老年人的醫療保健結果。

供體組織的供應有限

供體組織供應有限是市場上的一個主要挑戰，限制了研究和醫療應用的關鍵生物樣本的供應。這種短缺減緩了科學研究，阻礙了個人化醫療的進步，並限制了需要移植或再生治療的患者的治療選擇。捐贈者組織的短缺可能會加劇研究人員和醫療保健提供者之間的競爭，增加成本並減少獲得所需治療的機會。

COVID-19 的影響：

COVID-19 大流行擾亂了組織庫市場，由於關閉、勞動力減少和醫療設施使用受限而導致樣本收集、處理和分發延遲。隨著重點轉向與流行病相關的研究，研究活動也陷入停滯。此外，對病毒透過生物樣本傳播的擔憂帶來了新的倫理和安全考量。儘管有這些挑戰，疫情凸顯了組織庫在推動醫療保健和研究方面的重要性。

預計消耗品領域在預測期內將是最大的。

預計消耗品領域在預測期內將佔據最大的市場佔有率。這包括冷凍保存溶液、儲存容器、管瓶、移液管、培養基、無菌包裝材料等。高品質的耗材對於保持生物樣本的完整性和確保長期活力至關重要。研究和臨床應用對組織樣本的需求不斷成長，推動了這些材料的消費不斷增加，並推動市場成長。

預計移植產業在預測期內複合年成長率最高。

預計移植產業在預測期內將表現出最高的複合年成長率，因為保存的組織和器官對於移植手術的成功至關重要。組織庫為需要挽救生命的移植的患者提供腎臟、角膜和骨髓等保存樣本。器官移植需求的不斷成長以及保存和歸檔技術的進步相結合，擴大了組織庫服務，改善了移植結果，並解決了全球器官短缺問題。

佔比最大的地區：

由於醫學研究、移植和個人化醫療的進步，預計北美地區在預測期內將佔據最大的市場佔有率。該地區受益於強大的醫療基礎設施、強力的法規結構以及對器官移植和再生療法不斷成長的需求。此外，慢性病的日益普及和人口老化也增加了對保存組織的需求。

複合年成長率最高的地區：

預計亞太地區在預測期內將實現最高成長率。組織儲存和處理技術的創新正在提高組織庫的能力。這包括改進的冷凍保存技術和更好的儲存解決方案。制定嚴格的法規來確保組織庫的道德實踐，這可以透過確保安全來促進成長，也可以透過合規成本來抑製成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球組織庫市場：依產品類型

  • 組織保存介質
  • 消耗品
  • 儲存系統和設備
  • 實驗室器皿和設備
  • 保存和加工套件
  • 其他產品類型

第6章全球組織庫市場：依組織庫類型

  • 人體組織庫
    • 幹細胞庫
    • 臍帶血庫
    • 骨髓庫
    • 器官庫
    • 皮膚庫
    • 角膜銀行
  • 動物組織庫

第7章全球組織庫市場：依儲存技術分類

  • 冷凍保存
  • 冷凍的
  • 冷凍乾燥
  • 冷藏
  • 灌注系統

第8章全球組織庫市場：依應用分類

  • 研究與發展（R&D）
  • 再生醫學
  • 診斷用途
  • 移植
  • 其他用途

第9章全球組織庫市場：依最終使用者分類

  • 醫院和外科中心
  • 調查機構
  • 生物技術和製藥公司
  • 血液/器官庫
  • 其他最終用戶

第10章全球組織庫市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 公司概況

  • AMS Biotechnology Limited
  • BioLife Solutions, Inc.
  • Beckman Coulter
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Corning Incorporated
  • Helmer Scientific
  • Irvine Scientific
  • Medtronic plc
  • Paragon Bioservices, Inc.
  • The Cooper Companies, Inc.
  • TissueGenesis, Inc.
  • ViGene Biosciences, Inc.
  • Fujifilm Cellular Dynamics
Product Code: SMRC27880

According to Stratistics MRC, the Global Tissue Banking Market is accounted for $3.6 billion in 2024 and is expected to reach $5.7 billion by 2030 growing at a CAGR of 7.8% during the forecast period. Tissue banking involves the collection, processing, storage, and distribution of human tissue for medical research, education, and transplantation. Tissue banks obtain tissue from deceased donors or living donors during surgical procedures. The retrieved tissue undergoes rigorous testing and processing to ensure its safety and suitability for its intended use. It is then stored under controlled conditions, often cryogenically, until needed for transplantation or research purposes. Tissue banking plays a crucial role in advancing medical science and improving patient care by providing essential resources for research, education, and transplantation.

According to recent data released by the WHO, chronic diseases are one of the world's biggest problems, and they are responsible for roughly 60% of all fatalities globally.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and cancer, is driving the demand for tissue banking services. As these diseases often require advanced research, personalized treatment, and organ transplants, tissue banks play a crucial role in providing the necessary biological samples. This growing need for specialized tissues for research, diagnostics, and therapeutic purposes is fueling the expansion of the market, supporting advancements in healthcare and precision medicine.

Restraint:

Ethical concerns and regulatory hurdles

Ethical concerns and regulatory hurdles pose significant challenges in the market. Issues surrounding informed consent, donor privacy, and the potential misuse of biological samples create ethical dilemmas. Additionally, stringent regulations on tissue collection, storage, and distribution can slow down research and increase operational costs for tissue banks. These barriers may limit the availability of samples for scientific advancements, hindering progress in medical research, regenerative medicine, and personalized therapies.

Opportunity:

Increasing geriatric population

The increasing geriatric population is significantly impacting the market. As older adults are more susceptible to chronic diseases and require organ transplants or specialized treatments, the demand for preserved biological samples grows. Tissue banks are crucial in providing tissues for research, regenerative medicine, and transplantation, helping to address age-related health issues. This demographic shift is contributing to the expansion of the tissue banking market, driving innovation and improving healthcare outcomes for the elderly.

Threat:

Limited availability of donor tissues

The limited availability of donor tissues is a major challenge in the market, restricting the supply of critical biological samples for research and medical applications. This scarcity can lead to delays in scientific studies, hinder advancements in personalized medicine, and limit treatment options for patients requiring transplants or regenerative therapies. The shortage of donor tissues increases competition among researchers and healthcare providers, potentially driving up costs and reducing access to essential treatments.

Covid-19 Impact:

The COVID-19 pandemic disrupted the tissue banking market by causing delays in sample collection, processing, and distribution due to lockdowns, reduced workforce availability, and restricted access to medical facilities. Research activities were also slowed, as focus shifted to pandemic-related studies. Furthermore, concerns about virus transmission through biological samples raised new ethical and safety considerations. Despite these challenges, the pandemic highlighted the importance of tissue banking in advancing healthcare and research.

The consumables segment is projected to be the largest during the forecast period

The consumables segment is projected to account for the largest market share during the projection period. These include cryopreservation solutions, storage containers, vials, pipettes, culture media, and sterile packaging materials. High-quality consumables are critical for maintaining the integrity of biological samples and ensuring their long-term viability. The growing demand for tissue samples in research and clinical applications is driving increased consumption of these materials, fueling market growth.

The transplantation segment is expected to have the highest CAGR during the forecast period

The transplantation segment is expected to have the highest CAGR during the extrapolated period as stored tissues and organs are crucial for successful transplant procedures. Tissue banks provide preserved samples, such as kidneys, corneas, and bone marrow, for patients in need of life-saving transplants. The growing demand for organ transplants, coupled with advances in preservation and storage techniques, is driving the expansion of tissue banking services, improving transplant outcomes, and addressing organ shortages globally.

Region with largest share:

North America region is projected to account for the largest market share during the forecast period driven by advancements in medical research, transplantation, and personalized medicine. The region benefits from a strong healthcare infrastructure, robust regulatory frameworks, and increased demand for organ transplants and regenerative therapies. Additionally, a rising prevalence of chronic diseases and an aging population are contributing to the demand for preserved tissues.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period. Innovations in tissue preservation and processing technologies are enhancing the capabilities of tissue banks. This includes improved cryopreservation techniques and better storage solutions. Stringent regulations are being implemented to ensure ethical practices in tissue banking, which can both facilitate growth by ensuring safety and potentially restrain it due to compliance costs.

Key players in the market

Some of the key players in Tissue Banking market include AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Lonza Group AG, Corning Incorporated, Helmer Scientific, Irvine Scientific, Medtronic plc, Paragon Bioservices, Inc., The Cooper Companies, Inc., TissueGenesis, Inc., ViGene Biosciences, Inc. and Fujifilm Cellular Dynamics.

Key Developments:

In July 2023, Bio-Rad Laboratories, Inc. and QIAGEN N.Vannounced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital PCR technology.

In May 2023, Pfizer and Thermo Fisher Scientific Inc. announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries where advanced genomic testing has previously been limited or unavailable.

Types Covered:

  • Tissue Preservation Media
  • Consumables
  • Storage Systems & Equipment
  • Laboratory Instruments & Equipment
  • Preservation & Processing Kits
  • Other Types

Tissue Bank Types Covered:

  • Human Tissue Banks
  • Animal Tissue Banks

Storage Technologies Covered:

  • Cryopreservation
  • Freezing
  • Lyophilization
  • Cold Storage
  • Perfusion Systems

Applications Covered:

  • Research & Development (R&D)
  • Regenerative Medicine
  • Diagnostic Applications
  • Transplantation
  • Other Applications

End Users Covered:

  • Hospitals & Surgical Centers
  • Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Blood and Organ Banks
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Tissue Banking Market, By Product Type

  • 5.1 Introduction
  • 5.2 Tissue Preservation Media
  • 5.3 Consumables
  • 5.4 Storage Systems & Equipment
  • 5.5 Laboratory Instruments & Equipment
  • 5.6 Preservation & Processing Kits
  • 5.7 Other Product Types

6 Global Tissue Banking Market, By Tissue Bank Type

  • 6.1 Introduction
  • 6.2 Human Tissue Banks
    • 6.2.1 Stem Cell Banks
    • 6.2.2 Cord Blood Banks
    • 6.2.3 Bone Marrow Banks
    • 6.2.4 Organ Banks
    • 6.2.5 Skin Banks
    • 6.2.6 Corneal Banks
  • 6.3 Animal Tissue Banks

7 Global Tissue Banking Market, By Storage Technology

  • 7.1 Introduction
  • 7.2 Cryopreservation
  • 7.3 Freezing
  • 7.4 Lyophilization
  • 7.5 Cold Storage
  • 7.6 Perfusion Systems

8 Global Tissue Banking Market, By Application

  • 8.1 Introduction
  • 8.2 Research & Development (R&D)
  • 8.3 Regenerative Medicine
  • 8.4 Diagnostic Applications
  • 8.5 Transplantation
  • 8.6 Other Applications

9 Global Tissue Banking Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Surgical Centers
  • 9.3 Research Institutes
  • 9.4 Biotechnology & Pharmaceutical Companies
  • 9.5 Blood and Organ Banks
  • 9.6 Other End Users

10 Global Tissue Banking Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 AMS Biotechnology Limited
  • 12.2 BioLife Solutions, Inc.
  • 12.3 Beckman Coulter
  • 12.4 Bio-Rad Laboratories Inc.
  • 12.5 Thermo Fisher Scientific Inc.
  • 12.6 Lonza Group AG
  • 12.7 Corning Incorporated
  • 12.8 Helmer Scientific
  • 12.9 Irvine Scientific
  • 12.10 Medtronic plc
  • 12.11 Paragon Bioservices, Inc.
  • 12.12 The Cooper Companies, Inc.
  • 12.13 TissueGenesis, Inc.
  • 12.14 ViGene Biosciences, Inc.
  • 12.15 Fujifilm Cellular Dynamics

List of Tables

  • Table 1 Global Tissue Banking Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Tissue Banking Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Tissue Banking Market Outlook, By Tissue Preservation Media (2022-2030) ($MN)
  • Table 4 Global Tissue Banking Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 5 Global Tissue Banking Market Outlook, By Storage Systems & Equipment (2022-2030) ($MN)
  • Table 6 Global Tissue Banking Market Outlook, By Laboratory Instruments & Equipment (2022-2030) ($MN)
  • Table 7 Global Tissue Banking Market Outlook, By Preservation & Processing Kits (2022-2030) ($MN)
  • Table 8 Global Tissue Banking Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 9 Global Tissue Banking Market Outlook, By Tissue Bank Type (2022-2030) ($MN)
  • Table 10 Global Tissue Banking Market Outlook, By Human Tissue Banks (2022-2030) ($MN)
  • Table 11 Global Tissue Banking Market Outlook, By Stem Cell Banks (2022-2030) ($MN)
  • Table 12 Global Tissue Banking Market Outlook, By Cord Blood Banks (2022-2030) ($MN)
  • Table 13 Global Tissue Banking Market Outlook, By Bone Marrow Banks (2022-2030) ($MN)
  • Table 14 Global Tissue Banking Market Outlook, By Organ Banks (2022-2030) ($MN)
  • Table 15 Global Tissue Banking Market Outlook, By Skin Banks (2022-2030) ($MN)
  • Table 16 Global Tissue Banking Market Outlook, By Corneal Banks (2022-2030) ($MN)
  • Table 17 Global Tissue Banking Market Outlook, By Animal Tissue Banks (2022-2030) ($MN)
  • Table 18 Global Tissue Banking Market Outlook, By Storage Technology (2022-2030) ($MN)
  • Table 19 Global Tissue Banking Market Outlook, By Cryopreservation (2022-2030) ($MN)
  • Table 20 Global Tissue Banking Market Outlook, By Freezing (2022-2030) ($MN)
  • Table 21 Global Tissue Banking Market Outlook, By Lyophilization (2022-2030) ($MN)
  • Table 22 Global Tissue Banking Market Outlook, By Cold Storage (2022-2030) ($MN)
  • Table 23 Global Tissue Banking Market Outlook, By Perfusion Systems (2022-2030) ($MN)
  • Table 24 Global Tissue Banking Market Outlook, By Application (2022-2030) ($MN)
  • Table 25 Global Tissue Banking Market Outlook, By Research & Development (R&D) (2022-2030) ($MN)
  • Table 26 Global Tissue Banking Market Outlook, By Regenerative Medicine (2022-2030) ($MN)
  • Table 27 Global Tissue Banking Market Outlook, By Diagnostic Applications (2022-2030) ($MN)
  • Table 28 Global Tissue Banking Market Outlook, By Transplantation (2022-2030) ($MN)
  • Table 29 Global Tissue Banking Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 30 Global Tissue Banking Market Outlook, By End User (2022-2030) ($MN)
  • Table 31 Global Tissue Banking Market Outlook, By Hospitals & Surgical Centers (2022-2030) ($MN)
  • Table 32 Global Tissue Banking Market Outlook, By Research Institutes (2022-2030) ($MN)
  • Table 33 Global Tissue Banking Market Outlook, By Biotechnology & Pharmaceutical Companies (2022-2030) ($MN)
  • Table 34 Global Tissue Banking Market Outlook, By Blood and Organ Banks (2022-2030) ($MN)
  • Table 35 Global Tissue Banking Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.